Nivedita Gupta to Th1 Cells
This is a "connection" page, showing publications Nivedita Gupta has written about Th1 Cells.
Connection Strength
0.035
-
Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBV152: interim results from a double-blind, randomised, multicentre, phase 2 trial, and 3-month follow-up of a double-blind, randomised phase 1 trial. Lancet Infect Dis. 2021 07; 21(7):950-961.
Score: 0.035